Stories you’ll find in this week’s print edition of Adweek Eastern Edition

Exit Interview
Hal Riney talks candidly to Adweek about his reluctance to retire, getting “sandbagged” by Saturn, and what still inspires and irks him about the business.

The Best Medicine
$100 Mil. Novartis Account in Play
The contenders: four New York-based agencies. The prize: the creative account for a new prescription drug. Novartis’ review is the latest entry in the hot direct-to-consumer category, which has recorded more than $1.5 billion in media and creative billings in the past year.

Rumor Mill
While Omnicom is showing second-quarter earnings growth-and analysts are bullish on its stock-its share price fell last week following the resignation of a board member and rumors that The Wall Street Journal is preparing a story on the company.

At least three agencies have met with Gillette to discuss its $40 million Duracell account. The client has seen both roster and non-roster shops, but it’s unclear whether the discussions involve a new or existing assignment.
BBDO’s most recent Duracell work ended its run in February.

Out to Lunch
A man feels so comfortable during a lunch meeting with
JPMorgan Chase, he leans over and eats his banker’s pickle. It’s one of three offbeat scenarios in spots breaking today from Foote, Cone & Belding that emphasize customer experience over the bank’s products.

Whither Bates?
Havas has talked to Cordiant Communications Group about an acquisition, sources said. But how desirable are the assets of the troubled London-based network?

On the Road
At Rhode Island’s Duffy & Shanley, “nobody is cool,” says one of its designers. And, she points out, that’s its appeal. One of three major players left in the area, the Providence shop retains a small-town charm and a family feel.
What’s missing? Just a respectable softball team. Mae Anderson reports.